|
Market Closed -
OTC Markets
19:58:57 29/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 35.00 USD | +0.69% |
|
+1.74% | +21.53% |
| 10-27 | CSL Limited - Shareholder/Analyst Call | |
| 10-27 | Australian shares slip as banks outweigh mining gains; inflation data in focus | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,224B | |||||
| 662B | |||||
| 514B | |||||
| 388B | |||||
| 361B |
- Stock Market
- Stocks
- CSL Stock
- CSLLY Stock
- Charts CSL Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
